动脉粥样硬化转录组学揭示ARNTL为平滑肌细胞调控因子,结合临床与遗传数据可改善风险分层
本研究对BiKE颈动脉斑块队列(n=125)的批量微阵列数据进行去卷积分析,结合公共单细胞RNA测序数据,将间充质细胞亚群与患者临床数据、随访信息及冠状动脉疾病遗传变异关联。发现有症状患者斑块中1型巨噬细胞和周细胞比例较高,而经典和调节型平滑肌细胞比例较低,尤其女性;基于细胞分数的聚类识别出三个患者组,与斑块稳定性和卒中关联。ARNTL上游的CAD相关变异影响斑块间充质细胞分数,沉默ARNTL可增加收缩标志物表达并减弱增殖。
要点
- 有症状患者斑块中1型巨噬细胞和周细胞比例较高,经典和调节型平滑肌细胞比例较低,女性更显著。
- 基于斑块细胞分数的聚类识别出三个患者组,与斑块稳定性和长期随访卒中相关。
- ARNTL上游CAD相关变异影响斑块间充质细胞分数,沉默ARNTL增加收缩标志物并减弱增殖。
核心结论
- 结合单细胞RNA测序数据与临床、遗传和转录组数据可细化患者脆弱性和风险预测分层。
- ARNTL基因变异可能影响斑块中平滑肌细胞比例和功能,其作为平滑肌细胞增殖调控因子的作用需进一步研究。
研究设计与样本
- 对BiKE颈动脉斑块队列(n=125)的批量微阵列数据进行生物信息学去卷积分析,使用公共斑块单细胞RNA测序数据。
- 将去卷积细胞分数与患者临床数据和随访信息关联,并基于细胞分数对患者进行聚类。
- 进行定量性状位点分析,预测CAD相关遗传变异对斑块间充质细胞分数(cfQTL)和基因表达(eQTL)的影响。
- 体外沉默人颈动脉平滑肌细胞中的ARNTL并检测收缩标志物表达和细胞增殖。
主要发现
- 有症状患者斑块中1型巨噬细胞和周细胞分数较高,经典和调节型平滑肌细胞分数较低,尤其女性。
- 糖尿病或他汀治疗不影响细胞分数分布。
- 基于斑块细胞分数的聚类识别出三个患者组,其稳定性特征和卒中关联存在相对差异,长期随访中仍存在。
- 鉴定出多个与斑块间充质细胞分数相关的单核苷酸多态性,位于生物钟基因ARNTL上游。
- 体外沉默ARNTL增加人颈动脉平滑肌细胞收缩标志物表达并减弱细胞增殖。
临床怎么用
- 整合斑块转录组、遗传变异和临床数据可能有助于细化动脉粥样硬化患者的风险分层。
- ARNTL及其调控的平滑肌细胞增殖通路值得进一步研究作为潜在干预靶点。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: The role of vascular smooth muscle cells (SMCs) in atherosclerosis has evolved to indicate causal genetic links with the disease. Single cell RNA sequencing (scRNAseq) studies have identified multiple cell populations of mesenchymal origin within atherosclerotic lesions, including various SMC sub-phenotypes, but it is unknown how they relate to patient clinical parameters and genetics. Here, mesenchymal cell populations in atherosclerotic plaques were correlated with major coronary artery disease (CAD) genetic variants and functional analyses performed to identify SMC markers involved in the disease. METHODS: Bioinformatic deconvolution was done on bulk microarrays from carotid plaques in the Biobank of Karolinska Endarterectomies (BiKE, n = 125) using public plaque scRNAseq data and associated with patient clinical data and follow-up information. BiKE patients were clustered based on the deconvoluted cell fractions. Quantitative trait loci (QTLs) analyses were performed to predict the effect of CAD associated genetic variants on mesenchymal cell fractions (cfQTLs) and gene expression (eQTLs) in plaques. RESULTS: Lesions from symptomatic patients had higher fractions of Type 1 macrophages and pericytes, but lower fractions of classical and modulated SMCs compared with asymptomatic ones, particularly females. Presence of diabetes or statin treatment did not affect the cell fraction distribution. Clustering based on plaque cell fractions, revealed three patient groups, with relative differences in their stability profiles and associations to stroke, even during long-term follow-up. Several single nucleotide polymorphisms associated with plaque mesenchymal cell fractions, upstream of the circadian rhythm gene ARNTL were identified. In vitro silencing of ARNTL in human carotid SMCs increased the expression of contractile markers and attenuated cell proliferation. CONCLUSIONS: This study shows the potential of combining scRNAseq data with vertically integrated clinical, genetic, and transcriptomic data from a large biobank of human plaques, for refinement of patient vulnerability and risk prediction stratification. The study revealed novel CAD-associated variants that may be functionally linked to SMCs in atherosclerotic plaques. Specifically, variants in the ARNTL gene may influence SMC ratios and function, and its role as a regulator of SMC proliferation should be further investigated.
引用
- Narayanan S, Vuckovic S, Bergman O, et al. Atheroma transcriptomics identifies ARNTL as a smooth muscle cell regulator and with clinical and genetic data improves risk stratification. Eur Heart J. 2025. PMID: 39552248. doi:10.1093/eurheartj/ehae768
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。